Ospedale San Raffaele S.r.l.

Oncology and Hematologic Malignancies

Ospedale San Raffaele S.r.l. is involved in clinical research across several cancer and blood disorder areas, with activity spanning solid tumors and hematologic malignancies. Its studies include chronic lymphocytic leukemia, muscle-invasive bladder cancer, prostate cancer, head and neck cancer, non-small cell lung cancer, and intrahepatic cholangiocarcinoma.

  • Chronic lymphocytic leukemia
  • Prostate cancer and clinically relevant prostate cancer
  • Muscle-invasive bladder cancer
  • Head and neck cancer and non-small cell lung cancer
  • Intrahepatic cholangiocarcinoma

Research activity also includes biomarker-driven approaches, imaging for tumor detection, and perioperative or combination strategies in oncology.

Neurology and Neuroinflammatory Disease

The sponsor supports studies in multiple sclerosis, including relapsing-remitting and progressive forms, as well as research in migraine and neurodegenerative mechanisms. Additional work addresses Wolfram syndrome type 1, reflecting interest in complex neurological and neurogenetic conditions.

  • Relapsing-remitting multiple sclerosis
  • Progressive multiple sclerosis
  • Migraine
  • Wolfram syndrome type 1
  • Neurodegenerative phenomena

Its neurological portfolio also touches on immune-mediated pathways and nervous system injury linked to chronic disease.

Cardiovascular and Critical Care Medicine

Clinical research in cardiology and critical care includes conditions such as cardiogenic shock, cardiac arrest, acute respiratory distress syndrome, low-cardiac output syndrome, dilated cardiomyopathy, and myocarditis. The sponsor also studies advanced support settings and postoperative cardiac complications.

  • Cardiogenic shock and cardiac arrest
  • Acute respiratory distress syndrome
  • Low-cardiac output syndrome
  • Dilated cardiomyopathy and myocarditis
  • Perioperative cardiac support

Work in this area extends to thrombotic and bleeding risk, hemodynamic instability, and cardiopulmonary rescue care.

Autoimmune, Infectious, and Metabolic Disorders

The sponsor’s research covers immune-mediated and systemic diseases including IgG4-related disease, new-onset autoimmune type 1 diabetes, and virus-negative myocarditis. It also includes studies in HIV infection and early treated HIV-1, alongside metabolic and endocrine conditions such as Wolfram syndrome type 1.

  • IgG4-related disease
  • Autoimmune type 1 diabetes
  • Virus-negative myocarditis
  • HIV infection and HIV-1
  • Metabolic and endocrine syndromes

These studies reflect interest in immune regulation, chronic infection, and autoimmune tissue injury.

Rare Disease, Genetics, and Musculoskeletal Conditions

Ospedale San Raffaele S.r.l. also conducts research in rare genetic diseases and musculoskeletal disorders, including Duchenne muscular dystrophy, Von-Hippel Lindau disease, and arthroscopic anterior cruciate ligament reconstruction. Additional activity includes chronic pelvic pain syndrome and other complex pain-related conditions.

  • Duchenne muscular dystrophy
  • Von-Hippel Lindau disease
  • Anterior cruciate ligament reconstruction
  • Chronic pelvic pain syndrome
  • Genetic and rare disease research

Its portfolio includes neuromuscular biology, inherited disease mechanisms, and surgical pain management.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effect of Phosphocreatine Sodium and Sodium Chloride in Patients Treated by Medical Emergency Teams with Conditions like Rapid Breathing or Low Blood Pressure

    Not yet recruiting

    3 1 1
    Italy
  • Study on Lymph Node Changes in Chronic Lymphocytic Leukemia Patients Treated with Venetoclax

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of Hydroxychloroquine Effects in Patients with Resectable Head and Neck Cancer or Non-small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study of Ibrutinib for Patients with Chronic Lymphocytic Leukemia and TP53 Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on Ibrutinib and Venetoclax for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study on Tirzepatide for Improving Insulin Production in Patients with Wolfram Syndrome Type 1

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy